Related Experiment Video
Updated: Aug 2, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Pancreatic cancer: Advances and challenges
Christopher J Halbrook1, Costas A Lyssiotis2, Marina Pasca di Magliano3
1Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA 92697, USA; Institute for Immunology, University of California, Irvine, Irvine, CA 92697, USA; Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA 92868, USA.
Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer. Understanding its complex tumor microenvironment and metabolic alterations is key to improving patient survival rates.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with complex pathogenesis.
- Genetic factors driving PDAC have been extensively studied, but the tumor microenvironment's role is critical.
- Tumor microenvironment orchestrates metabolic alterations and cellular interactions within the pancreatic cancer niche.
Purpose of the Study:
- To review foundational studies on pancreatic cancer biology and the tumor microenvironment.
- To discuss recent technological advances enhancing the understanding of PDAC complexity.
- To highlight the clinical translation potential of research for improving PDAC survival.
Main Methods:
- Literature review of foundational and recent studies on PDAC.
- Analysis of research on tumor microenvironment and metabolic alterations.
- Synthesis of technological advancements impacting PDAC research.
Main Results:
- Major genetic drivers of PDAC pathogenesis are well-defined.
- The pancreatic tumor microenvironment significantly influences cancer progression through metabolic alterations and cell-cell interactions.
- Recent technological advances are providing deeper insights into PDAC complexity.
Conclusions:
- A comprehensive understanding of PDAC pathogenesis requires integrating genetic factors with the tumor microenvironment.
- Translating research findings on tumor biology and microenvironment into clinical practice is essential.
- Improving the dismal survival rates for pancreatic ductal adenocarcinoma necessitates continued research and clinical application.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis II: Clinical Manifestations and Management

